Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 25Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Breast Neoplasms 13Colonic Neoplasms 9Uterine Cervical Neoplasms 7Lung Neoplasms 6Colorectal Neoplasms 6Urinary Bladder Neoplasms 5Melanoma 5Leukemia, Myeloid, Acute 5Carcinoma, Renal Cell 5Uterine Cervical Dysplasia 4Lymphoma, Large B-Cell, Diffuse 4Esophageal Neoplasms 4Brain Neoplasms 4Thrombocythemia, Essential 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycythemia Vera 3Papillomavirus Infections 3Oropharyngeal Neoplasms 3Neuroblastoma 3Mouth Neoplasms 3Liver Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Glioma 3Gallbladder Neoplasms 3Carcinoma, Hepatocellular 3

Interventions

binimetinib 2Watchful Waiting 2Sodium Chloride 2Aminolevulinic Acid 2palbociclib 1methyl 5-aminolevulinate 1ipatasertib 1exemestane 1encorafenib 1baricitinib 1atezolizumab 1Vemurafenib 1VP-102 1Trabectedin 1Spironolactone 1Radiotherapy 1Radiation 1Photochemotherapy 1Paclitaxel 1Low-Level Light Therapy 1Leuprolide 1Injections, Intradermal 1Gonadotropin-Releasing Hormone 1Fluorouracil 1Floderm topical cream 1Everolimus 1Equipment and Supplies 1Docetaxel 1Dacarbazine 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Skin Diseases × Watchful Waiting × Clear all
NCT05080907 2022-11-09

Collection and Distribution of Biospecimens for Novel Research

iSpecimen Inc

Unknown
100,000 enrolled

Autoimmune Diseases, Communicable Diseases, Hematologic Diseases, Neoplasms, Skin Diseases

NCT04016935 2022-05-17

EndoPredict® Extended Endocrine Trial (EXET)

Myriad Genetic Laboratories, Inc.

Terminated
855 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡